Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CCS | HHH |
|---|---|---|
| Price | $58.89 | $73.28 |
| Change today | ▲ 1.31% | ▲ 2.26% |
| Market cap | $1.67B | $4.38B |
| Return, 3 months | -7.0% | +1.4% |
| Return, year to date | +0.7% | -8.1% |
| Return, 1 year | +3.3% | -11.8% |
| P/E (TTM) | 12.9 | 14.5 |
| P/B | 0.7 | 1.1 |
| P/E percentile vs own 5y | 91st | 36th |
| Dividend yield | 2.07% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | +22.1% |
| Analyst buy share | – | 50% |
| RSI (14) | 37 | 64 |
| 30-day volatility | 31.3% | 44.5% |
| Max drawdown, 1 year | -35.0% | -33.0% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
